Home Cart 0 Sign in  
X

[ CAS No. 4654-39-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4654-39-1
Chemical Structure| 4654-39-1
Chemical Structure| 4654-39-1
Structure of 4654-39-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4654-39-1 ]

Related Doc. of [ 4654-39-1 ]

Alternatived Products of [ 4654-39-1 ]

Product Details of [ 4654-39-1 ]

CAS No. :4654-39-1 MDL No. :MFCD00002897
Formula : C8H9BrO Boiling Point : -
Linear Structure Formula :- InChI Key :PMOSJSPFNDUAFY-UHFFFAOYSA-N
M.W : 201.06 Pubchem ID :72851
Synonyms :

Calculated chemistry of [ 4654-39-1 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 2
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 45.08
TPSA : 20.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.48 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.07
Log Po/w (XLOGP3) : 1.47
Log Po/w (WLOGP) : 1.98
Log Po/w (MLOGP) : 2.61
Log Po/w (SILICOS-IT) : 2.68
Consensus Log Po/w : 2.16

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.32
Solubility : 0.952 mg/ml ; 0.00474 mol/l
Class : Soluble
Log S (Ali) : -1.5
Solubility : 6.34 mg/ml ; 0.0315 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.49
Solubility : 0.0652 mg/ml ; 0.000324 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.16

Safety of [ 4654-39-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4654-39-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4654-39-1 ]
  • Downstream synthetic route of [ 4654-39-1 ]

[ 4654-39-1 ] Synthesis Path-Upstream   1~38

  • 1
  • [ 4654-39-1 ]
  • [ 52914-23-5 ]
Reference: [1] Journal of the American Chemical Society, 2014, vol. 136, # 7, p. 2711 - 2714
[2] Patent: WO2005/63239, 2005, A1, . Location in patent: Page/Page column 134
  • 2
  • [ 4654-39-1 ]
  • [ 98-80-6 ]
  • [ 37729-18-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 14, p. 4199 - 4203
  • 3
  • [ 4654-39-1 ]
  • [ 1553-60-2 ]
Reference: [1] Organic Process Research and Development, 2006, vol. 10, # 5, p. 1076 - 1079
  • 4
  • [ 41841-16-1 ]
  • [ 4654-39-1 ]
YieldReaction ConditionsOperation in experiment
85.5% With lithium borohydride In tetrahydrofuran at 0 - 20℃; for 2 h; 5.5a (6 g, 26.2 mmol, 1.0equiv) was dissolved in THE (100 mL) and cooled toO °C. LiBH4 (2M in THE) (1.41 g, 52.4 mmol, 2.0 equiv) was added drop wise at 0 °C and the reaction mixture was stirred at room temperature for 2 hours. The reaction mixture was quenched with water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate and concentrated to afford product 5.5b (4.5 g, 85.5 percent yield). LCMS (mlz): 204.8 [M+H]. 1H NMR (400 MHz, DMSO) 6 7.56 — 7.35 (m, 2H), 7.27 — 7.07 (m, 2H), 4.67 (t, J = 5.2 Hz, 1 H), 3.58 (td, J = 6.8, 5.4 Hz, 2H), 2.69 (t, J = 6.9 Hz, 2H).
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 11, p. 5627 - 5631
[2] Patent: WO2015/66413, 2015, A1, . Location in patent: Page/Page column 164; 165
[3] Chemistry - A European Journal, 2015, vol. 21, # 42, p. 14737 - 14741
[4] Advanced Synthesis and Catalysis, 2012, vol. 354, # 10, p. 1879 - 1884
[5] Synthesis, 2011, # 18, p. 2935 - 2940
  • 5
  • [ 75-21-8 ]
  • [ 106-37-6 ]
  • [ 4654-39-1 ]
YieldReaction ConditionsOperation in experiment
85%
Stage #1: With n-butyllithium In diethyl ether; hexane at -40 - 20℃; for 3 h; Inert atmosphere
Stage #2: at -40 - 20℃; for 1 h; Inert atmosphere
The solution of 1,4-dibromobenzene (40 g, 0.17 mol) in drydiethyl ether (200 mL) was cooled to 40 C and n-buthyllithium(105.6 mL, 1.6 M in hexanes, 0.17 mol) was added dropwise for1 h. The mixture was allowed to warm up to rt and stirred for2 h. The reaction was once again cooled to 40 C and a solutionof ethylene epoxide (8.46 mL, 0.17 mol) in 40 mL of diethyl etherwas added slowly to the mixture. The reaction mixture was slowlywarmed to room temperature and stirred for 1 h at room temperature.Then 40 mL of NH4Cl was added to quench the reaction. Theproduct was extracted with diethyl ether (3 100 mL). Theorganic layers were dried over MgSO4, filtered and concentrated.Distillation afforded 28.63 g (85percent) of a colourless liquid of 10.
Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 12, p. 3465 - 3472
[2] Organic and Biomolecular Chemistry, 2010, vol. 8, # 15, p. 3552 - 3562
[3] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1977, p. 2357 - 2364
  • 6
  • [ 1878-68-8 ]
  • [ 4654-39-1 ]
YieldReaction ConditionsOperation in experiment
99%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran at 0 - 20℃; for 3 h;
Stage #2: With hydrogenchloride; water In tetrahydrofuran at 0 - 80℃; for 0.5 h;
4-r2-(2-Bromoethoxy)ethvnbenzonitrile(T) 2-(4-BromophenvDethanol To a chilled solution (about O0C) of 4-bromophenyl acetic acid (25 g, 0.116 mol) in THF (250 mL), borane methyl sulphide (13.2 g, 0.174 mol) was added, dropwise, under nitrogen atmosphere. The reaction mixture was stirred at room temperature for 3 h. After cooling the mixture to between 0 and 5°C, the reaction was quenched by adding 1.5 NHCl (80 mL), dropwise. After warming for 30 min at about 800C, the reaction mixture was extracted with ethyl acetate (2 x 100 mL). The combined organic extracts were washed with water and brine and then dried. The product was obtained as colourless liquid after concentration (yield: 23.3 g, 99percent).
18.7g With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 30℃; for 2 h; The specific operation is as follows: The bromophenylacetic acid was added to 200ml of tetrahydrofuran,Stirring cooled to 0 ° C after adding lithium aluminum hydride in batches, the end of the addition,After the reaction was heated to 25 ~ 30 ° C for 2h, 300ml of water and 400ml of dichloromethane were separated,The organic phase was added to 20g of anhydrous sodium sulfate, filtered and the filtrate was concentrated under reduced pressure at 30-35 ° C.Obtained light yellow oil (brominated S1-1): 18.7g, under ice bath,To bromine S1-1 was added dropwise phosphorus tribromide, dropping temperature during the control at 0 ~ 10 ,Dropping is completed, incubated 10min insulation, a white smoke generated, stirring, warming to 75 ~ 80 ,After stirring for 2h, 30ml of saturated sodium bicarbonate solution, 200ml of ethyl acetate,Stirring 20min liquid separation, the organic phase 40 ~ 45 filtrate was concentrated under reduced pressure,A yellow liquid (bromination S2) was obtained: 22.1 g. Yield: 90.0percent.
Reference: [1] Patent: WO2006/135316, 2006, A1, . Location in patent: Page/Page column 64
[2] European Journal of Inorganic Chemistry, 2011, # 14, p. 2238 - 2246
[3] Advanced Synthesis and Catalysis, 2016, vol. 358, # 3, p. 452 - 458
[4] Chemical Communications (Cambridge, United Kingdom), 2012, vol. 48, # 85, p. 10514 - 10516,3
[5] European Journal of Medicinal Chemistry, 2016, vol. 122, p. 786 - 801
[6] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 3, p. 756 - 760
[7] Journal of Organic Chemistry, 1964, vol. 29, # 8, p. 2109 - 2116
[8] Chemical and Pharmaceutical Bulletin, 1977, vol. 25, # 7, p. 1732 - 1739
[9] Tetrahedron, 1990, vol. 46, # 20, p. 7247 - 7262
[10] Tetrahedron Letters, 1989, vol. 30, # 46, p. 6291 - 6294
[11] Journal of Medicinal Chemistry, 1991, vol. 34, # 9, p. 2882 - 2891
[12] Bulletin of the Chemical Society of Japan, 2005, vol. 78, # 10, p. 1856 - 1861
[13] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 18, p. 4752 - 4756
[14] Synthetic Communications, 1998, vol. 28, # 5, p. 823 - 832
[15] Journal of the American Chemical Society, 2010, vol. 132, # 12, p. 4076 - 4077
[16] European Journal of Organic Chemistry, 2011, # 17, p. 3178 - 3183
[17] Synthesis, 2011, # 18, p. 2935 - 2940
[18] Chemistry - A European Journal, 2011, vol. 17, # 47, p. 13349 - 13357
[19] Patent: WO2015/66413, 2015, A1,
[20] Chemistry - A European Journal, 2014, vol. 20, # 47, p. 15325 - 15329
[21] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 2, p. 131 - 134
[22] Patent: CN106478506, 2017, A, . Location in patent: Paragraph 0133; 0134
  • 7
  • [ 50-00-0 ]
  • [ 589-17-3 ]
  • [ 4654-39-1 ]
YieldReaction ConditionsOperation in experiment
54%
Stage #1: With chloro-trimethyl-silane; ethylene dibromide; zinc In tetrahydrofuran at 70℃; for 2 h; Schlenk technique; Inert atmosphere
Stage #2: at 70℃; for 6 h; Schlenk technique; Inert atmosphere
General procedure: Phenethyl alcohol (3a) A two neck Schlenk flask equipped with a magnetic stirring bar and septum was heated with heat gun (~400 °C) for 10 min under high vacuum. After cooling to room temperature, the flask was flushed with argon (3 times). Zn-dust (654 mg, 2.0 equiv, 10.0 mmol) was added followed by THF (20 mL). 1,2-Dibromoethane (5 molpercent) was added and the reaction mixture was heated until ebullition occurs. After cooling to rt, chlorotrimethylsilane (1 molpercent) was added and the mixture was heated again till ebullition occurs. The flask was again cooled to rt and benzyl chloride (633 mg, 5.0 mmol, 1 equiv) was added as a solution in THF (10 mL) and it was heated at 70 °C for 2 h and cooled to rt. Paraformaldehyde (450 mg, 3.0 equiv. 15.0 mmol) was slowly added at rt and the flask was again heated at 70 °C for 6 h. The solution was cooled to rt and saturated NH4Cl solution was added. The phases were separated and the aqueous layer was extracted with ethyl acetate (100 mL). The combined organic layer was washed with water (20 mL), brine (10 mL) and then dried over Na2SO4. The solvents were evaporated under reduced pressure and the residue was purified by silica gel column chromatography using cyclohexane or cyclohexane/ethyl acetate as an eluent to obtain phenethyl alcohol (3a) (510 mg, 83percent) as a colourless liquid.
Reference: [1] Synthetic Communications, 2017, vol. 47, # 10, p. 968 - 974
  • 8
  • [ 32017-76-8 ]
  • [ 4654-39-1 ]
Reference: [1] Chemical Communications, 2015, vol. 51, # 12, p. 2294 - 2297
[2] Journal of Organic Chemistry, 1957, vol. 22, p. 93
[3] Chemical Communications, 2017, vol. 53, # 31, p. 4308 - 4311
  • 9
  • [ 4360-68-3 ]
  • [ 4654-39-1 ]
Reference: [1] Organic Process Research and Development, 2006, vol. 10, # 5, p. 1076 - 1079
  • 10
  • [ 14062-25-0 ]
  • [ 4654-39-1 ]
Reference: [1] Chemistry - A European Journal, 2015, vol. 21, # 7, p. 2785 - 2788
  • 11
  • [ 2039-82-9 ]
  • [ 4654-39-1 ]
  • [ 5391-88-8 ]
Reference: [1] Synlett, 2000, # 7, p. 997 - 998
[2] Tetrahedron Letters, 2000, vol. 41, # 31, p. 5817 - 5819
[3] Patent: EP1167329, 2002, A2, . Location in patent: Page 8
  • 12
  • [ 2039-82-9 ]
  • [ 25015-63-8 ]
  • [ 5391-88-8 ]
  • [ 4654-39-1 ]
  • [ 5391-88-8 ]
Reference: [1] Journal of the American Chemical Society, 2004, vol. 126, # 30, p. 9200 - 9201
  • 13
  • [ 74860-13-2 ]
  • [ 4654-39-1 ]
Reference: [1] Journal of the American Chemical Society, 2014, vol. 136, # 6, p. 2268 - 2271
  • 14
  • [ 2039-82-9 ]
  • [ 4654-39-1 ]
Reference: [1] Science, 2011, vol. 333, # 6049, p. 1609 - 1612
[2] Patent: US6150413, 2000, A,
[3] ACS Catalysis, 2017, vol. 7, # 8, p. 5225 - 5233
[4] Science, 2017, vol. 358, # 6360, p. 215 - 218
  • 15
  • [ 1878-68-8 ]
  • [ 4654-39-1 ]
  • [ 27200-79-9 ]
Reference: [1] Chemical Communications (Cambridge, United Kingdom), 2012, vol. 48, # 85, p. 10514 - 10516,3
  • 16
  • [ 60-12-8 ]
  • [ 4654-39-1 ]
Reference: [1] Journal of Organic Chemistry, 2018, vol. 83, # 2, p. 930 - 938
  • 17
  • [ 60-12-8 ]
  • [ 4654-39-1 ]
  • [ 1074-16-4 ]
Reference: [1] Synlett, 2004, # 15, p. 2739 - 2745
  • 18
  • [ 1878-68-8 ]
  • [ 4654-39-1 ]
  • [ 1313039-90-5 ]
Reference: [1] European Journal of Organic Chemistry, 2011, # 17, p. 3178 - 3183
  • 19
  • [ 75-21-8 ]
  • [ 18620-02-5 ]
  • [ 4654-39-1 ]
Reference: [1] Journal of the American Chemical Society, 1948, vol. 70, p. 4177
[2] Iowa State College Journal of Science, 1943, vol. 18, p. 65
  • 20
  • [ 2039-82-9 ]
  • [ 5391-88-8 ]
  • [ 4654-39-1 ]
Reference: [1] Synlett, 2012, vol. 23, # 20, p. 2957 - 2960
  • 21
  • [ 60-12-8 ]
  • [ 4654-39-1 ]
  • [ 122-78-1 ]
  • [ 103-63-9 ]
Reference: [1] Journal of Physical Organic Chemistry, 2008, vol. 21, # 11, p. 945 - 953
  • 22
  • [ 99-90-1 ]
  • [ 4654-39-1 ]
Reference: [1] Organic Process Research and Development, 2006, vol. 10, # 5, p. 1076 - 1079
  • 23
  • [ 32017-76-8 ]
  • [ 4654-39-1 ]
  • [ 5391-88-8 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1987, vol. 60, p. 1813 - 1818
  • 24
  • [ 1122-91-4 ]
  • [ 4654-39-1 ]
Reference: [1] Chemical Communications, 2017, vol. 53, # 31, p. 4308 - 4311
  • 25
  • [ 16532-79-9 ]
  • [ 4654-39-1 ]
Reference: [1] Journal of Organic Chemistry, 1964, vol. 29, # 8, p. 2109 - 2116
  • 26
  • [ 589-15-1 ]
  • [ 4654-39-1 ]
Reference: [1] Journal of Organic Chemistry, 1964, vol. 29, # 8, p. 2109 - 2116
  • 27
  • [ 104-10-9 ]
  • [ 4654-39-1 ]
Reference: [1] Journal of the Chemical Society, 1936, p. 181,183
[2] Journal of the Chemical Society, 1935, p. 1819
  • 28
  • [ 4654-39-1 ]
  • [ 75-86-5 ]
  • [ 57775-08-3 ]
Reference: [1] Patent: US6335350, 2002, B1, . Location in patent: Example 78
[2] Patent: EP1137645, 2004, B1, . Location in patent: Page 45
  • 29
  • [ 4654-39-1 ]
  • [ 57775-08-3 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1977, p. 2357 - 2364
  • 30
  • [ 60-12-8 ]
  • [ 4654-39-1 ]
  • [ 1074-16-4 ]
Reference: [1] Synlett, 2004, # 15, p. 2739 - 2745
  • 31
  • [ 4654-39-1 ]
  • [ 46112-46-3 ]
Reference: [1] Journal of the American Chemical Society, 1948, vol. 70, p. 4177
  • 32
  • [ 109-72-8 ]
  • [ 60-29-7 ]
  • [ 124-38-9 ]
  • [ 4654-39-1 ]
  • [ 46112-46-3 ]
Reference: [1] Journal of the American Chemical Society, 1948, vol. 70, p. 4177
[2] Iowa State College Journal of Science, 1943, vol. 18, p. 65
  • 33
  • [ 4654-39-1 ]
  • [ 149910-98-5 ]
Reference: [1] Pharmazie, 1996, vol. 51, # 9, p. 641 - 644
[2] Tetrahedron Letters, 2013, vol. 54, # 30, p. 3962 - 3964
[3] Tetrahedron Letters, 2014, vol. 55, # 50, p. 6821 - 6826
[4] Chemistry - A European Journal, 2014, vol. 20, # 47, p. 15325 - 15329
[5] Advanced Synthesis and Catalysis, 2016, vol. 358, # 12, p. 1880 - 1885
[6] Journal of Organic Chemistry, 2016, vol. 81, # 15, p. 6463 - 6471
[7] Organic and Biomolecular Chemistry, 2016, vol. 14, # 44, p. 10366 - 10370
[8] Chemistry - A European Journal, 2017, vol. 23, # 45, p. 10871 - 10877
[9] Organic Letters, 2018,
  • 34
  • [ 3970-21-6 ]
  • [ 4654-39-1 ]
  • [ 149910-98-5 ]
Reference: [1] Journal of Organic Chemistry, 2013, vol. 78, # 7, p. 3104 - 3112
  • 35
  • [ 4654-39-1 ]
  • [ 137756-89-9 ]
YieldReaction ConditionsOperation in experiment
63%
Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 1.5 h;
Stage #2: With hydrogenchloride; Triisopropyl borate In tetrahydrofuran; hexane; water at -78 - 20℃; for 1 h;
To a stirred solution of 4-bromophenethylalcohol (5.00 g, 24.9 mmol) in THF (80 ml) was added a solution of 1.5M n-BuLi in hexane (39.8 ml, 59.7 mmol) at -78° C. over 30 min. After 1 hour, a solution of B(OiPr)3 (8.61 ml, 37.3 mmol) in THF (20 ml) was added slowly to the mixture at -78° C. The resultant mixture was warmed to room temperature, and treated with 2M HCl (100 ml) for 1 hour. This was extracted with CH2Cl2 and dried over MgSO4, then filtered. After evaporation in vacuo, the residue was purified by silica-gel column chromatography eluting with CH2Cl2/MeOH=20/1 to afford 2.61 g (63percent) of the title compound. [2789] 1H-NMR (CD3OD) δ: 7.64-7.48 (2H, m), 7.19-7.13 (2H, m), 3.70 (2H, t, J=7.2 Hz), 2.77 (2H, t, J=7.2 Hz) MS (ESI) m/z: 165 ([M-H]-)
63% With n-butyllithium; Triisopropyl borate In tetrahydrofuran; hexane at -78 - 20℃; for 1.5 h; To a stirred solution of 4-bromophenethylalcohol (5.00 g, 24.9 mmol) in tetrahydrofuran (80 mL) was added a solution of 1.5 M n-butyl lithium in hexane (39.8 mL, 59.7 mmol) at -78° C. over 30 min. After 1 h, a solution of triisopropyl borate (8.61 mL, 37.3 mmol) in tetrahydrofuran (20 mL) was added slowly to the mixture at -78° C. The resultant mixture was warmed to room temperature, and treated with 2 M HCl (100 mL) for 1 h. This mixture was extracted with dichloromethane and dried (MgSO4). After evaporation in vacuo, the residue was purified by silica-gel column chromatography eluting with dichloromethane/methanol (20:1) to afford 2.61 g (63percent) of the title compound as white solids
Reference: [1] Patent: US2003/236260, 2003, A1, . Location in patent: Page 114
[2] Patent: US2004/19045, 2004, A1, . Location in patent: Page 52
  • 36
  • [ 5419-55-6 ]
  • [ 4654-39-1 ]
  • [ 7732-18-5 ]
  • [ 137756-89-9 ]
YieldReaction ConditionsOperation in experiment
37%
Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78 - 35℃; for 1.5 h;
Stage #2: at -78 - 35℃;
Stage #3: With ammonium chloride In tetrahydrofuran; hexane
(Step 1)
To a solution of 2-(4-bromophenyl)ethanol (3.00 g, 14.9 mmol) in THF (60 mL) was added 1.6 M butyllithium/hexane solution (23.3 mL, 37.3 mmol) at -78° C. and the mixture was stirred at -78° C. for 1 hr and then at room temperature for 30 min.
The reaction mixture was cooled again to -78° C. and triisopropylboric acid (7.02 g, 37.3 mmol) was added.
The mixture was gradually heated to room temperature.
Saturated aqueous ammonium chloride solution (150 mL) was added and the mixture was extracted with ethyl acetate.
The organic layer was washed with saturated brine, and dried over anhydrous-sodium sulfate.
The solvent was evaporated under reduced pressure, and the concentrated residue was purified by silica gel column chromatography (67-100percent ethyl acetate/hexane-9percent methanol/ethyl acetate) to give [4-(2-hydroxyethyl)phenyl]boronic acid as a colorless amorphous form (925 mg, 37percent).
Reference: [1] Patent: US2015/329556, 2015, A1, . Location in patent: Paragraph 1862-1863
  • 37
  • [ 4654-39-1 ]
  • [ 137756-89-9 ]
YieldReaction ConditionsOperation in experiment
63% With hydrogenchloride; n-butyllithium In tetrahydrofuran; hexane Step. 4-(2-hydroxyethyl)phenylboronic acid
To a stirred solution of 4-bromophenethylalcohol (5.00 g, 24.9 mmol) in THF (80 ml) was added a solution of 1.5M n-BuLi in hexane (39.8 ml, 59.7 mmol) at -78° C. over 30 min.
After 1 hour, a solution of B(OiPr)3 (8.61 ml, 37.3 mmol) in THF (20 ml) was added slowly to the mixture at -78° C.
The resultant mixture was warmed to room temperature, and treated with 2M HCl (100 ml) for 1 hour.
This was extracted with CH2Cl2 and dried over MgSO4, then filtered.
After evaporation in vacuo, the residue was purified by silica-gel column chromatography eluding with CH2Cl2/MeOH=20/1 to afford 2.61 g (63percent) of the title compound.
1H-NMR (CD3OD) δ: 7.64-7.48 (2H, m), 7.19-7.13 (2H, m), 3.70 (2H, t, J=7.2 Hz), 2.77 (2H, t, J=7.2 Hz)
MS (ESI) m/z: 165 ([M-H]-)
Reference: [1] Patent: US2002/77329, 2002, A1,
  • 38
  • [ 4654-39-1 ]
  • [ 73183-34-3 ]
  • [ 651030-55-6 ]
YieldReaction ConditionsOperation in experiment
100% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 85℃; for 12 h; Inert atmosphere Step 1: 2-(4-(4,4,5,5-Tetramethyl-l,3)2-dioxaborolan-2-yl)phenyl)ethanol Potassium acetate (4.88 g, 49.7 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(l,3,2-dioxaborolane) (7.6 g, 30 mmol) and PdCl2(dppf) (0.91 g, 1.2 mmol) were added to a solution of 2-(4-bromophenyl)ethanoi (5.0 g, 25 mmol) in 1 ,4-dioxane (100 mL) under 2, The mixture was purged with N2 then stirred under N2 at about 85 °C for about 12 h. After cooling to rt, water (100 mL) was added and the mixture was extracted with EtOAc (2 χ 100 mL). The combined organic layers were washed with saturated aqueous NaCl (100 mL) and dried over Na2S04, filtered and concentrated under reduced pressure. The residue was purified via flash chromatography on silica gel (17percent EtOAc/petroleum ether). The appropriate fractions were collected and concentrated under reduced pressure to give the title compound (6.2 g, 100percent). NMR (400MHz, (.' )(. I :) δ 7.78 (d, J = 7.9 Hz, 2H), 7.29 - 7.23 (m, 2H), 3.87 (t, J= 6.6 Hz, 2H), 2.90 t, J = 6.6 Hz, 2H), 1.36 (s, 12H).
100% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 85℃; for 12 h; Inert atmosphere Step 1: 2-(4-(4,4,5,5-Tetramethyl-l,3,2-dioxaborolan-2-yl)phenyl)ethanol KOAc (4.88 g, 49.7 mmol), 4,4,4,,4',5,5,5',5'-octamethyl-2,2'-bi(l,3,2-d.ioxaborolane) (7.6 g, 30 mmol) and PdCl2(dppf) (0.91 g, 1.2 mmol) were added to a solution of 2-(4-bromophenyl)ethanol (5.0 g, 25 mmol) in 1,4-dioxane (100 mL) under N2. The mixture was purged with N2 then stirred under N2 at about 85 °C for about 12 h. After cooling to rt, water (100 mL) was added and the mixture was extracted with EtOAc (2 x 100 mL). The combined organic layers were washed with sat. aq.NaCl (100 mL) and dried over Na2S04, filtered and concentrated under reduced pressure. The residue was purified by flash chromatography on silica gel (17percent EtO Ac/petroleum ether). The appropriate fractions were collected and concentrated under reduced pressure to afford the title product (6.2 g, 100percent). NMR (400MHz, CDC13) δ 7.78 (d, ,/ = 7.9 Hz, 2H), 7.29 - 7.23 (m, 2H), 3.87 (t, ,/ = 6.6 Hz, 2H), 2.90 (t, ,/ = 6.6 Hz, 2H), 1.36 (s, 12H).
100% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 85℃; for 12 h; Inert atmosphere Potassium acetate (4.88 g, 49.7 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(l,3,2-dioxaborolane) (7.6 g, 30 mmol) and PdCl2(dppf) (0.91 g, 1.2 mmol) were added to a solution of 2-(4-bromophenyl)ethanol (5.0 g, 25 mmol) in 1,4-dioxane (100 mL) under N2. The mixture was purged with N2 then stirred under N2 at about 85 °C for about 12 h. After cooling to rt, water (100 mL) was added and the mixture was extracted with EtOAc (2 χ 100 mL). The combined organic layers were washed with saturated aqueous NaCl (100 mL) and dried over Na2SOzi, filtered and concentrated under reduced pressure. The residue was purified via flash chromatography on silica gel (17percent EtO Ac/petroleum ether). The appropriate fractions were collected and concentrated under reduced pressure to give the title compound (6.2 g, 100percent). NMR (400MHz, CDC13) δ 7.78 (d, J= 7.9 Hz, 2H), 7.29 - 7.23 (m, 2H), 3.87 (t, J= 6.6 Hz, 2H), 2.90 (t, J= 6.6 Hz, 2H), 1.36 (s, 12H).
89% With potassium acetate In dimethyl sulfoxide at 120℃; for 5 h; To a solution of 2-(4-bromophenyl)ethanol (500mg, 2.49mmol) in dimethyl sulfoxide (5mL) were added bis (pinacolato) diboron (632mg, 2.49mmol), potassium acetate (733mg, 7.47mmol) and [1,1'-bis (diphenylphosphino)ferrocene]dichloropalladium(II)-dichloromethane (1:1) complex (102mg, 124μmol), and the mixture was stirred for 5 hours at 120°C. Ice water and toluene were added to the reaction mixture and the insolubles were filtered off. The organic layer was separated, washed with water, then dried over anhydrous sodium sulfate, and solvent was distilled off. The residue obtained was purified by silica gel column chromatography [hexane-ethyl acetate=1:1], thereby affording 455mg of the title compound as a pale yellow oil. Yield 89percent.1H-NMR (CDCl3, δ): 1.34(12H,s), 2.89(2H,t,J=6.3Hz), 3.87(2H,q, J=6.3Hz), 7.25(2H,d,J=7.8Hz), 7.77(2H,d,J=8.3Hz).
79% With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In 1,4-dioxane at 80℃; Inert atmosphere PdCI2(dppf)-CH2Cl2 adduct (4.06 g, 4.97 mmol) was added to a solution of 2-(4- bromophenyl)ethanol (10.0 g, 49.7 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1 ,3,2- dioxaborolane) (25.3 g, 99 mmol) and potassium acetate (14.64 g, 149 mmol) in 1 ,4- dioxane (200 ml_) at room temperature under a nitrogen atmosphere and the reaction mixture was stirred at 80 °C overnight. The mixture was concentrated under reduced pressure and the residue was purified by silica gel chromatography (1 :6 EtOAc/petroleum ether) to give 2-(4-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)phenyl)ethanol (10.5 g, 39.2 mmol, 79 percent yield) as a yellow oil. LCMS: [M+NH4] 266.2.
73% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride In 1,4-dioxane at 100℃; for 18 h; Inert atmosphere To a 1L flask was added Bis(pinacolato)diboron (30.5 g, 0.12 mol), KOAc (29.44 g, 0.3 mol) and1,1’-Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (5 mmol, 0.05 eq.). The flask was charged under Ar and dioxane (250 mL) was introduced and the resulting mixture was purged with Ar for 15 mm. To it was added 2-(4-bromophenyl)-ethanol (14 ml, 0.1 mol) and the mixture was then heated at 100 °C for 18 h. It was cooled to room temperature and was filtered through celite.The filtrate was concentrated and the residue was diluted with EtOAc. The organic solution was washed with brine and driver over Mg504. Concentration afforded the crude product, which was further purified on a silica-gel column with 30-80percent EtOAc in hexane to give 18.1 g (73percent) of 2-(4- (4,4,5,5-tetramethyl- 1,3 ,2-dioxaborolan-2-yl)phenyl)ethanol

Reference: [1] Patent: WO2016/168638, 2016, A1, . Location in patent: Page/Page column 30; 31
[2] Patent: WO2016/168633, 2016, A1, . Location in patent: Page/Page column 57
[3] Patent: WO2016/168641, 2016, A1, . Location in patent: Page/Page column 105
[4] Journal of the American Chemical Society, 2014, vol. 136, # 42, p. 14742 - 14745
[5] Patent: EP1544194, 2005, A1, . Location in patent: Page/Page column 37-38
[6] Patent: WO2017/98440, 2017, A1, . Location in patent: Page/Page column 150
[7] Patent: WO2016/11019, 2016, A1, . Location in patent: Page/Page column 160
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4654-39-1 ]

Aryls

Chemical Structure| 28229-69-8

[ 28229-69-8 ]

3-Bromophenethyl alcohol

Similarity: 0.97

Chemical Structure| 25574-11-2

[ 25574-11-2 ]

3-(4-Bromophenyl)propan-1-ol

Similarity: 0.94

Chemical Structure| 65537-54-4

[ 65537-54-4 ]

3-(3-Bromophenyl)propan-1-ol

Similarity: 0.91

Chemical Structure| 17100-58-2

[ 17100-58-2 ]

(4-Bromo-2-methylphenyl)methanol

Similarity: 0.91

Chemical Structure| 171011-37-3

[ 171011-37-3 ]

(4-Bromo-1,2-phenylene)dimethanol

Similarity: 0.91

Bromides

Chemical Structure| 28229-69-8

[ 28229-69-8 ]

3-Bromophenethyl alcohol

Similarity: 0.97

Chemical Structure| 25574-11-2

[ 25574-11-2 ]

3-(4-Bromophenyl)propan-1-ol

Similarity: 0.94

Chemical Structure| 65537-54-4

[ 65537-54-4 ]

3-(3-Bromophenyl)propan-1-ol

Similarity: 0.91

Chemical Structure| 17100-58-2

[ 17100-58-2 ]

(4-Bromo-2-methylphenyl)methanol

Similarity: 0.91

Chemical Structure| 171011-37-3

[ 171011-37-3 ]

(4-Bromo-1,2-phenylene)dimethanol

Similarity: 0.91

Alcohols

Chemical Structure| 28229-69-8

[ 28229-69-8 ]

3-Bromophenethyl alcohol

Similarity: 0.97

Chemical Structure| 25574-11-2

[ 25574-11-2 ]

3-(4-Bromophenyl)propan-1-ol

Similarity: 0.94

Chemical Structure| 65537-54-4

[ 65537-54-4 ]

3-(3-Bromophenyl)propan-1-ol

Similarity: 0.91

Chemical Structure| 17100-58-2

[ 17100-58-2 ]

(4-Bromo-2-methylphenyl)methanol

Similarity: 0.91

Chemical Structure| 171011-37-3

[ 171011-37-3 ]

(4-Bromo-1,2-phenylene)dimethanol

Similarity: 0.91